During the financial year 2023/24, the busiest hospital provider in England was the ************************************************ with over *** thousand admissions. This trust encompasses four hospitals in the Birmingham area, one of the largest urban areas in England. The second-busiest trust this year was the ******************************************, with approximately *** thousand admissions. Accident and emergency admissionsFrom April to June 2023, there were around *** million accident and emergency (A&E) attendees (including at A&E departments not in hospitals) in England. After the drop in A&E attendances during the COVID-pandemic, numbers have risen again to previous levels, with a trend towards an increasing number of individuals seeking emergency care. Over ***** percent of A&E attendees in England in 2022/23 were first diagnosed with a sprained ankle, knee, wrist, or foot, and over **** percent were diagnosed with a respiratory infection. Furthermore, *** percent were found to have ‘no abnormality detected’ which could be detrimental to a service that is already stretched. Waiting too longOver the last few years in the A&E department, the NHS has been falling behind the target that ** percent of patients should be seen within **** hours of arrival. The last time this target was reached was back in July 2015. Not just the A&E department, but other services also require lengthy waits. It is no wonder that the ******** of respondents surveyed were fairly or very dissatisfied with the length of wait for many aspects of NHS care. Moreover, in general, levels of satisfaction with the way NHS runs is at an all-time low.

In 2022, there were an estimated 2,001 hospitals in the United Kingdom. The number of hospitals in the UK had been declining prior to 2015, standing at 1,568 in 2014, before slightly rising again in the subsequent years.

Healthcare indicators

Expenditure on health in the UK amounted to 11.3 percent of the GDP in 2022. This proportion has been increasing since 2000, with 2020 and 201 being outliers. The pressure on general practices has been increasing in the UK in the last ten years. In 2016, there were 7.8 thousand patients to each GP practice on average in the NHS England. By 2023 it came to ten thousand patients to a practice.

Opinion of healthcare in the country

The quality of British healthcare is still generally regarded as good by the majority. In a survey of nine European countries, 58 percent of British respondents rated the quality of their accessible healthcare as good, while only 14 percent regarded it as poor. This was the fifth place among countries surveyed, down from its top spot in 2018, when 73 percent of the public gave good rating. Similarly, 58 percent of Brits surveyed trusted the treatment offered, compared to only 18 percent who did not.

Hospital services are currently being stretched at the seams as they struggle to navigate financial constraints and workforce shortages while appointment waiting times remain high. Hospitals faced unrivalled pressure during the COVID-19 outbreak and this necessitated the release of significant government funding to help hospitals boost their capacity to treat afflicted patients. According to the King’s Fund, NHS funding rose from £148.9 billion in 2019-20 to £191 billion in 2020-21. Hospitals are still facing long elective backlogs, growing by around 100,000 cases monthly, according to the BMA. Over the five years through 2024-25, industry revenue is therefore expected to marginally rise at a compound annual rate of 0.2% to reach £115.1 billion. Hospitals are contending with stagnant real-term funding growth, exacerbated by inflationary pressures in the three years through 2024-25 and increasing demand for healthcare services due to a growing and ageing population. NHS England has a planned 2024-25 budget of £165 billion in real terms, which is only a 0.2% rise on 2023-24. In March 2025, the government announced plans to abolish NHS England, in a move to remove administrative hurdles it feels are preventing improvements in the hospital sector. Hospitals have been pressured to manage costs while dealing with a workforce crisis, highlighted by dependency on temporary staff to maintain safe staffing levels. Public healthcare budgets have failed to keep pace with soaring demand. Hospitals are struggling to match pre-COVID-19 activity levels, which has boosted demand for private hospitals as more patients seek private treatment. As a result, industry revenue is projected to grow by 0.9% in 2024-25. Revenue is estimated to climb at a compound annual rate of 2.3% over the five years through 2029-30 to £128.7 billion. Hospitals’ performance will depend on how much funding is available for an already over-burdened institution. The Labour government’s plan for hospitals over the next decade will be released in spring 2025 which will determine what resources are at the industry’s disposal in the coming years. With workforce shortages projected to worsen without substantial investments in training and recruitment, hospitals will need a plan to build a sustainable long-term staffing model. Dependency on international recruitment will become more of a challenge as global healthcare systems grapple with their own workforce shortages. Embracing technological advancements and digitisation like virtual wards will be key to improving efficiency and patient care, with planned capital funding aimed at transforming medical technology.

This publication reports on Admitted Patient Care activity in England for the financial year 2023-24. This report includes but is not limited to analysis of hospital episodes by patient demographics, diagnoses, external causes/injuries, operations, bed days, admission method, time waited, specialty, provider level analysis and Adult Critical Care (ACC). It describes NHS Admitted Patient Care Activity, Adult Critical Care activity and performance in hospitals in England. The purpose of this publication is to inform and support strategic and policy-led processes for the benefit of patient care and may also be of interest to researchers, journalists and members of the public interested in NHS hospital activity in England. The data source for this publication is Hospital Episode Statistics (HES). It contains final data and replaces the provisional data that are released each month. HES contains records of all admissions, appointments and attendances at NHS-commissioned hospital services in England. The HES data used in this publication are called 'Finished Consultant Episodes', and each episode relates to a period of care for a patient under a single consultant at a single hospital. Therefore, this report counts the number of episodes of care for admitted patients rather than the number of patients. This publication shows the number of episodes during the period, with breakdowns including by patient's age, gender, diagnosis, procedure involved and by provider. Please send queries or feedback via email to enquiries@nhsdigital.nhs.uk. Author: Secondary Care Open Data and Publications, NHS England. Lead Analyst: Karl Eichler

Hospital Episodes Statistics (HES) is a data warehouse containing records of all patients admitted to NHS hospitals in England. It contains details of every hospital stay in English NHS Hospitals and English NHS commissioned activity in the independent sector. The Kennedy report recommended that HES should be "supported as a major national resource for the monitoring of a range of healthcare outcomes". Note: (04/02/13) An update to the Hospital Episode Statistics: Admitted Patient Care 2011-12 Summary Report has been published. Chart 3 has been updated to include 2011-12 data. Note: (28/01/13) An update to the Hospital Episode Statistics: Admitted Patient Care 2011-12 Summary Report has been published. This updates and corrects the 2011-12 figure for bariatric surgery for obesity to include new OPCS 4.6 procedure codes that were introduced in April 2011

Snapshot img

Hospital Beds Market Size 2025-2029

The hospital beds market size is forecast to increase by USD 2.69 billion, at a CAGR of 9.9% between 2024 and 2029.

The market is experiencing significant growth due to the rising number of medical emergencies and the increase in infectious diseases. The global health crisis has highlighted the importance of having an adequate supply of hospital beds to manage the influx of patients. However, the high cost of automated hospital beds poses a challenge for healthcare providers, as they seek to balance the need for advanced technology with budget constraints. Moreover, the growing prevalence of chronic diseases, such as diabetes and cardiovascular diseases, necessitates long-term hospitalization, further increasing the demand for hospital beds. Additionally, the aging population and their subsequent healthcare needs are also contributing to market growth.
To capitalize on these opportunities, companies can focus on developing cost-effective solutions that offer advanced features, ensuring they cater to the evolving needs of healthcare providers while remaining competitive in the market. Navigating the challenges of cost and affordability will be crucial for market success, as providers seek to optimize their budgets while maintaining the highest level of patient care.

What will be the Size of the Hospital Beds Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The hospital bed market continues to evolve, with dynamic shifts in market trends and applications across various healthcare sectors. Hospital bed frames, a fundamental component of patient care, undergo constant innovation to enhance ergonomics and support systems. Mattresses with advanced pressure distribution technology cater to the unique needs of bariatric patients, while ICU beds integrate intravenous pole systems and height adjustment mechanisms for intensive care. Bedside safety features, such as fall prevention systems and bedside rails, are increasingly integrated into hospital bed designs. Bedside monitors, lighting, and call systems further enhance patient safety and comfort. Hospital bed sustainability is a growing concern, with a focus on recycling and disposal methods, as well as the use of eco-friendly materials in bed covers and linens.

Anti-embolism stockings and durability are essential considerations in hospital bed design, ensuring patient safety and longevity. Hospital bed certification standards continue to evolve, driving innovation in bedside safety and maintenance. The market for hospital bed accessories, such as overbed tables and height adjustment mechanisms, is expanding to cater to diverse patient needs. Ergonomics and aesthetics are increasingly important in hospital bed design, with a focus on patient comfort and satisfaction. The integration of electric actuators and sterilization systems further enhances the functionality and efficiency of hospital beds. The ongoing development of pressure relief systems and anti-decubitus mattresses underscores the continuous pursuit of innovation in this dynamic market.

How is this Hospital Beds Industry segmented?

The hospital beds industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Manual beds
  Semi-automated beds
  Automated beds


Application

  Intensive care
  Acute care
  Home care


End-user

  Hospitals
  Home healthcare
  Elderly care facilities
  Ambulatory surgical centers


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    UK


  APAC

    China
    India
    Japan
    South Korea


  South America

    Brazil


  Rest of World (ROW)

.

By Product Insights

The manual beds segment is estimated to witness significant growth during the forecast period.

The market encompasses a range of products designed for healthcare settings, including manual and electric beds, bariatric beds, ICU beds, and recovery room beds. These beds prioritize ergonomics, offering mattress support systems, adjustable frames, and pressure distribution systems to ensure patient comfort and support. Hospital bed sustainability is a growing concern, leading to the development of eco-friendly materials and recycling programs for bed components. Bedside tables, rails, and lighting provide added functionality, while certifications ensure safety and compliance. Hospital bed linens and covers, along with anti-embolism stockings, contribute to patient care and hygiene. Fall prevention systems and repair services ensure patient safety and bed longevity.

Operating room tables and electric actuators facilitate

The size of the UK Hospital Supplies Industry market was valued at USD 29.5 Billion in 2023 and is projected to reach USD 34.7 Billion by 2032, with an expected CAGR of 5.60% during the forecast period. The hospital supplies industry in the United Kingdom is a vital component of the country's healthcare system, characterized by a comprehensive range of medical supplies and equipment essential for patient care. The UK has a well-established healthcare infrastructure, primarily through the National Health Service (NHS), which provides services to a significant portion of the population. The hospital supplies market encompasses various products, including surgical instruments, medical consumables, durable medical equipment, and infection control supplies. The UK has a comprehensive healthcare system supported by the NHS, which plays a significant role in providing medical services and supplies. This extensive infrastructure creates a consistent demand for hospital supplies to support patient care and operations. Recent developments include: In April 2022, the United Kingdom donated to Ukraine 5.29 million items of medical supplies to help the country cope with the medical emergency, which includes lifesaving medicines, wound packs, and intensive care equipment., In July 2020, BD (Becton, Dickinson, and Company) announced the receipt of a large pandemic order from the United Kingdom (U.K.) government for 65 million needles and syringes to be d.elivered by mid-September 2020 to support the U.K. vaccination effort for COVID-19.. Key drivers for this market are: The aging population in the UK is leading to a higher prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and other age-related conditions. This demographic shift drives demand for hospital supplies and medical services. . Potential restraints include: The UK healthcare system operates under a budget-constrained model, which can pressure hospitals to control costs. This may limit their ability to invest in advanced hospital supplies and technologies. . Notable trends are: There is a growing trend toward the use of disposable medical supplies in hospitals due to concerns about infection control and convenience. The demand for single-use products is expected to rise, particularly in surgical and emergency care settings. .

In 2023, 64 percent of services received at NHS acute hospitals were considered good, whereas 25 percent required improvement. This statistic displays the overall rating of NHS acute hospitals core services in England as of August 2023.

This data package contains the hospital bed availability and occupancy data by consultant main specialty and sector as well as data on inpatient and outpatient related hospital activity in England. It also contains information on Sub-Saharan public hospitals.

Hospital Episode Statistics (HES) is a database containing details of all admissions, A and E attendances and outpatient appointments at NHS hospitals in England. Initially this data is collected during a patient's time at hospital as part of the Commissioning Data Set (CDS). This is submitted to NHS Digital for processing and is returned to healthcare providers as the Secondary Uses Service (SUS) data set and includes information relating to payment for activity undertaken. It allows hospitals to be paid for the care they deliver. This same data can also be processed and used for non-clinical purposes, such as research and planning health services. Because these uses are not to do with direct patient care, they are called 'secondary uses'. This is the HES data set. HES data covers all NHS Clinical Commissioning Groups (CCGs) in England, including: private patients treated in NHS hospitals patients resident outside of England care delivered by treatment centres (including those in the independent sector) funded by the NHS Each HES record contains a wide range of information about an individual patient admitted to an NHS hospital, including: clinical information about diagnoses and operations patient information, such as age group, gender and ethnicity administrative information, such as dates and methods of admission and discharge geographical information such as where patients are treated and the area where they live We apply a strict statistical disclosure control in accordance with the NHS Digital protocol, to all published HES data. This suppresses small numbers to stop people identifying themselves and others, to ensure that patient confidentiality is maintained. https://digital.nhs.uk/data-and-information/publications/statistical/hospital-outpatient-activity

United Kingdom Hospital Market, By Ownership, By Type, Size, By Type of Services, By Bed Capacity, By Region, Competition, Forecast & Opportunities, 2017-2027F

The UK hospital supplies market, a significant segment of the broader European healthcare landscape, is experiencing robust growth driven by several key factors. An aging population, increasing prevalence of chronic diseases, and advancements in medical technology are fueling demand for a wider range of sophisticated hospital supplies. Government initiatives promoting improved healthcare infrastructure and patient care further contribute to market expansion. The market is segmented by product type, with patient examination devices, operating room equipment, and disposable supplies representing significant portions of the overall revenue. Technological innovations, such as minimally invasive surgical tools and advanced diagnostic equipment, are reshaping the market, leading to increased efficiency and improved patient outcomes. However, budgetary constraints within the National Health Service (NHS) and stringent regulatory requirements represent potential challenges to sustained, rapid growth. Competitive pressures from both domestic and international suppliers also influence market dynamics, encouraging innovation and price optimization. Despite these challenges, the market is projected to maintain a healthy growth trajectory. The focus on preventative healthcare and the increasing adoption of telehealth solutions are expected to drive demand for certain product categories, particularly remote monitoring devices and telehealth-compatible equipment. Furthermore, the UK's commitment to improving its healthcare system, along with investments in research and development, should support a positive outlook for the hospital supplies market in the coming years. Companies operating in this market are likely to focus on strategic partnerships, mergers, and acquisitions to expand their product portfolios and market reach, capitalizing on opportunities presented by the evolving healthcare landscape in the UK. Given the 5.60% CAGR observed globally, a conservative estimate for the UK market would likely fall within the range of 4-6%, reflecting the complexities of the NHS and the regional economic factors. Recent developments include: In April 2022, the United Kingdom donated to Ukraine 5.29 million items of medical supplies to help the country cope with the medical emergency, which includes lifesaving medicines, wound packs, and intensive care equipment., In July 2020, BD (Becton, Dickinson, and Company) announced the receipt of a large pandemic order from the United Kingdom (U.K.) government for 65 million needles and syringes to be d.elivered by mid-September 2020 to support the U.K. vaccination effort for COVID-19.. Key drivers for this market are: Increasing Incidences of Communal Diseases, Growing Public Awareness about Hospital Acquired Infections. Potential restraints include: Increasing Incidences of Communal Diseases, Growing Public Awareness about Hospital Acquired Infections. Notable trends are: Disposable Hospital Supplies Holds the Major Share in the Market Studied.

This horizontal bar chart displays hospital beds (per 1,000 people) by countries yearly using the aggregation average, weighted by population in the United Kingdom. The data is filtered where the date is 2021. The data is about countries per year.

Crude rate of cost of admissions for alcohol-related conditions (Broad definition) per head of population.

Rationale Alcohol misuse across the UK is a significant public health problem with major health, social, and economic consequences. This indicator aims to highlight the impact of alcohol-related conditions on inpatient hospital services in England. High costs of alcohol-related admissions are indicative of poor population health and high alcohol consumption. This indicator highlights the resource implications of alcohol-related conditions and supports the arguments for local health promotion initiatives. Publication of this indicator will allow national and local cost estimates to be updated and consistently monitored going forward. This measure accounts for just one aspect of the cost of alcohol to society, but there are others such as primary care, crime, ambulatory services, and specialist treatment services as well as broader costs such as unemployment and loss of productivity.

The Government has said that everyone has a role to play in reducing the harmful use of alcohol. This indicator is one of the key contributions by the Government (and the Department of Health and Social Care) to promote measurable, evidence-based prevention activities at a local level, and supports the national ambitions to reduce harm set out in the Government's Alcohol Strategy. This ambition is part of the monitoring arrangements for the Responsibility Deal Alcohol Network. Alcohol-related admissions can be reduced through local interventions to reduce alcohol misuse and harm.

References: (1) PHE (2020) The Burden of Disease in England compared with 22 peer countries https://www.gov.uk/government/publications/global-burden-of-disease-for-england-international-comparisons/the-burden-of-disease-in-england-compared-with-22-peer-countries-executive-summary

Definition of numerator The total cost (£s) of alcohol-related admissions (Broad). Admissions to hospital where the primary diagnosis is an alcohol-related condition, or a secondary diagnosis is an alcohol-related external cause.

More specifically, hospital admissions records are identified where the admission is a finished episode [epistat = 3]; the admission is an ordinary admission, day case or maternity [classpat = 1, 2 or 5]; it is an admission episode [epiorder = 1]; the sex of the patient is valid [sex = 1 or 2]; there is a valid age at start of episode [startage between 0 and 150 or between 7001 and 7007]; the region of residence is one of the English regions, no fixed abode or unknown [resgor <= K or U or Y]; the episode end date [epiend] falls within the financial year, and an alcohol-attributable ICD10 code appears in the primary diagnosis field [diag_01] or an alcohol-related external cause code appears in any diagnosis field [diag_nn].

For each episode identified, an alcohol-attributable fraction is applied to the primary diagnosis field or an alcohol-attributable external cause code appears in one of the secondary codes based on the diagnostic codes, age group, and sex of the patient. Where there is more than one alcohol-related ICD10 code among the 20 possible diagnostic codes, the code with the largest alcohol-attributable fraction is selected; in the event of there being two or more codes with the same alcohol-attributable fraction within the same episode, the one from the lowest diagnostic position is selected. For a detailed list of all alcohol-attributable diseases, including ICD 10 codes and relative risks, see ‘Alcohol-attributable fractions for England: an update’ (2). Alcohol-related hospital admission episodes were extracted from HES according to the Broad definition and admissions flagged as either elective or non-elective based on the admission method field.

The cost of each admission episode was calculated using the National Cost Collection (published by NHS England) main schedule dataset for the corresponding financial year applied to elective and non-elective admission episodes. The healthcare resource group (HRG) was identified using the HES field SUSHRG [SUS Generated HRG], which is the SUS PbR derived HRG code at episode level. Healthcare Resource Groups (HRGs) are standard groupings of clinically similar treatments which use common levels of healthcare resource. The elective admissions were assigned an average of the elective and day-case costs. The non-electives were assigned an average of the non-elective long stay and non-elective short stay costs. Where the HRG was not available or did not match the National Reference Costs look-up table, an average elective or non-elective cost was imputed. This may result in the cost of these admissions being underestimated. For each record, the AAF was multiplied by the reference cost and the resulting values were aggregated by the required output geographies to provide numerators for the cost per capita indicator.

References: (2) PHE (2020) Alcohol-attributable fractions for England: an update https://www.gov.uk/government/publications/alcohol-attributable-fractions-for-england-an-update

Definition of denominator Mid-year population estimates.

Caveats Not all alcohol-related conditions require inpatient services, so this indicator is only one measure of the alcohol-related health problems in each local area. However, inpatient admissions are easily monitored, and this indicator provides local authorities with a routine method of monitoring the health impacts of alcohol in their local populations.

The Healthcare Resource Group cost assigned to each hospital admission is for the initial admission episode only and doesn’t include costs related to alcohol in any subsequent episodes in the hospital spell. Where the HRG was not available or did not match the National Reference Costs look-up table, an average elective or non-elective cost was imputed. This may result in the cost of these admissions being underestimated. It must be noted that the numerator is based on the financial year and the denominator on calendar mid-year population estimates, e.g., 2019/20 admission rates are constructed from admission counts for the 2019/20 financial year and mid-year population estimates for the 2020 calendar year. Data for England includes records with geography 'No fixed abode'. Alcohol-attributable fractions were not available for children. Conditions where low levels of alcohol consumption are protective (have a negative alcohol-attributable fraction) are not included in the calculation of the indicator. This does not include attendance at Accident and Emergency departments. Hospital Episode Statistics overall is well completed. However, year-on-year variations exist due to poor completion from a proportion of trusts.

Analysis has revealed significant differences across the country in the coding of cancer patients in the Hospital Episode Statistics. In particular, in some areas, regular attenders at hospital for treatments like chemotherapy and radiotherapy are being incorrectly recorded as ordinary or day-case admissions. Since cancer admissions form part of the overarching alcohol-related admission national indicators, the inconsistent recording across the country for cancer patients has some implication for these headline measures.

Cancer admissions make up approximately a quarter of the total number of alcohol-related admissions. Analysis suggests that, although most Local Authorities would remain within the same RAG group compared with the England average if cancer admissions were removed, the ranking of Local Authorities within RAG groups would be altered. We are continuing to monitor the impact of this issue and to consider ways of improving the consistency between areas. The COVID-19 pandemic had a large impact on hospital activity with a reduction in admissions in 2020 to 2021. Because of this, NHS Digital has been unable to analyse coverage (measured as the difference between expected and actual records submitted by NHS Trusts) in the normal way. There may have been issues around coverage in some areas which were not identified as a result.

The SHMI is the ratio between the actual number of patients who die following hospitalisation at the trust and the number that would be expected to die on the basis of average England figures, given the characteristics of the patients treated there. It includes deaths which occurred in hospital and deaths which occurred outside of hospital within 30 days (inclusive) of discharge. The SHMI gives an indication for each non-specialist acute NHS trust in England whether the observed number of deaths within 30 days of discharge from hospital was 'higher than expected' (SHMI banding=1), 'as expected' (SHMI banding=2) or 'lower than expected' (SHMI banding=3) when compared to the national baseline. Trusts may be located at multiple sites and may be responsible for 1 or more hospitals. A breakdown of the data by site of treatment is also provided. The SHMI is composed of 144 different diagnosis groups and these are aggregated to calculate the overall SHMI value for each trust. The number of finished provider spells, observed deaths and expected deaths at diagnosis group level for each trust is available in the SHMI diagnosis group breakdown files. For a subset of diagnosis groups, an indication of whether the observed number of deaths within 30 days of discharge from hospital was 'higher than expected', 'as expected' or 'lower than expected' when compared to the national baseline is also provided. Details of the 144 diagnosis groups can be found in Appendix A of the SHMI specification. Notes: 1. For discharges in the reporting period April 2024 - May 2024, most of the records for Wirral University Teaching Hospital NHS Foundation Trust (trust code RBL) have been submitted without an NHS number. This will have affected the linkage of the HES data to the ONS death registrations data and may have resulted in a smaller number of deaths occurring outside hospital within 30 days of discharge being identified for this trust than would have otherwise been the case. The results for this trust should therefore be interpreted with caution. 2. Northern Lincolnshire and Goole NHS Foundation Trust (trust code RJL) has a high percentage of records with no NHS Number. This is resulting in around 40% of their spells not having a value for Age or Deprivation rank. As Age is a component of the statistical models used to calculate the SHMI, values for this trust should therefore be interpreted with caution. 3. There is a shortfall in the number of records for North Middlesex University Hospital NHS Trust (trust code RAP), Northumbria Healthcare NHS Foundation Trust (trust code RTF), The Rotherham NHS Foundation Trust (trust code RFR), and The Shrewsbury and Telford Hospital NHS Trust (trust code RXW). Values for these trusts are based on incomplete data and should therefore be interpreted with caution. 4. There is a high percentage of records with missing data for the Sex field for Guy’s and St Thomas’ NHS Foundation Trust (trust code RJ1) and University Hospitals Dorset NHS Foundation Trust (trust code R0D). Values for these trusts should therefore be interpreted with caution. 5. There is a high percentage of invalid diagnosis codes for Bradford Teaching Hospitals NHS Foundation Trust (trust code RAE), Chesterfield Royal Hospital NHS Foundation Trust (trust code RFS), East Lancashire Hospitals NHS Trust (trust code RXR), Harrogate and District NHS Foundation Trust (trust code RCD), Portsmouth Hospitals University NHS Trust (trust code RHU), University Hospitals of North Midlands NHS Trust (trust code RJE), and University Hospitals Plymouth NHS Trust (trust code RK9). Values for these trusts should therefore be interpreted with caution. 6. A number of trusts are now submitting Same Day Emergency Care (SDEC) data to the Emergency Care Data Set (ECDS) rather than the Admitted Patient Care (APC) dataset. The SHMI is calculated using APC data. Removal of SDEC activity from the APC data may impact a trust’s SHMI value and may increase it. More information about this is available in the Background Quality Report. 7. Further information on data quality can be found in the SHMI background quality report, which can be downloaded from the 'Resources' section of this page.

Improving outcomes for people with multiple long term conditions is a priority as set out in the NHS long term plan. ADMISSION is a Research Collaborative funded by UK Research and Innovation and the National Institute for Health Research and Care Research that brings together scientists, clinicians and patients from five UK universities and hospitals (Newcastle University and Newcastle Hospitals NHS Foundation Trust, University of Birmingham (PIONEER – the Health Data Research UK Acute Care Hub),  Manchester Metropolitan University, University of Dundeeand University College London) to transform understanding of multiple long-term conditions in hospital patients.

As part of this, PIONEER has curated a highly granular dataset of 119,815 unique hospitalised patients focusing on the impact of multiple long term conditions. The data includes admission details, demography, initial presentation, presenting symptoms, diagnoses, treatments, therapy, medications, imaging, wards, investigations, procedures, operations and outcomes. The current dataset includes admissions from 01-01-2000 to 07-02-2024 but can be expanded to assess other timelines of interest.

Geography: The West Midlands (WM) has a population of 6 million & includes a diverse ethnic & socio-economic mix. UHB is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & > 120 ITU bed capacity. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”.

Data set availability: Data access is available via the PIONEER Hub for projects which will benefit the public or patients. This can be by developing a new understanding of disease, by providing insights into how to improve care, or by developing new models, tools, treatments, or care processes. Data access can be provided to NHS, academic, commercial, policy and third sector organisations. Applications from SMEs are welcome. There is a single data access process, with public oversight provided by our public review committee, the Data Trust Committee. Contact pioneer@uhb.nhs.uk or visit www.pioneerdatahub.co.uk for more details.

Available supplementary data: Matched controls; ambulance and community data. Unstructured data (images). We can provide the dataset in OMOP and other common data models and can build synthetic data to meet bespoke requirements.

Available supplementary support: Analytics, model build, validation & refinement; A.I. support. Data partner support for ETL (extract, transform & load) processes. Bespoke and “off the shelf” Trusted Research Environment (TRE) build and run. Consultancy with clinical, patient & end-user and purchaser access/ support. Support for regulatory requirements. Cohort discovery. Data-driven trials and “fast screen” services to assess population size.

This publication of the SHMI relates to discharges in the reporting period February 2024 - January 2025. The SHMI is the ratio between the actual number of patients who die following hospitalisation at the trust and the number that would be expected to die on the basis of average England figures, given the characteristics of the patients treated there. The SHMI covers patients admitted to hospitals in England who died either while in hospital or within 30 days of being discharged. To help users of the data understand the SHMI, trusts have been categorised into bandings indicating whether a trust's SHMI is 'higher than expected', 'as expected' or 'lower than expected'. For any given number of expected deaths, a range of observed deaths is considered to be 'as expected'. If the observed number of deaths falls outside of this range, the trust in question is considered to have a higher or lower SHMI than expected. The expected number of deaths is a statistical construct and is not a count of patients. The difference between the number of observed deaths and the number of expected deaths cannot be interpreted as the number of avoidable deaths or excess deaths for the trust. The SHMI is not a measure of quality of care. A higher than expected number of deaths should not immediately be interpreted as indicating poor performance and instead should be viewed as a 'smoke alarm' which requires further investigation. Similarly, an 'as expected' or 'lower than expected' SHMI should not immediately be interpreted as indicating satisfactory or good performance. Trusts may be located at multiple sites and may be responsible for 1 or more hospitals. A breakdown of the data by site of treatment is also provided, as well as a breakdown of the data by diagnosis group. Further background information and supporting documents, including information on how to interpret the SHMI, are available on the SHMI homepage (see Related Links).

London was the city in the United Kingdom with the highest costs for constructing a general hospital in 2024. Meanwhile, among cities included in this selection, Leeds was the cheapest one to build that kind of structure. The expenses of such a construction in London were over *** British pounds higher than in Glasgow. The capital of the UK is the most expensive area for public building construction. Hospital bed numbers still in decline The number of hospital beds in the UK has been declining since 2000. Between 2000 and 2020, figures decreased from ******* to ******* number of beds. The reduction in hospital beds is, among other reasons, attributed to technical improvements in surgery rooms, patients with mental health problems being treated in different settings, and most importantly, cuts to NHS funding. However, the number of beds increased slightly again in 2021 and 2022. Increased healthcare spend Despite past funding cuts and declining availability of hospital beds, healthcare spending has significantly increased in the past twenty years. In 2022, expenditure reached a peak of nearly *** billion British pounds, whereas in 2000, this figure amounted to ** billion British pounds. The value of healthcare expenditure as a share of GDP also increased significantly in the past years.

These files comprise the publicly available data for the COG-UK hospital-onset COVID-19 infection study. The individual CSV files provided are: - HOCI_public_dataset: Anonymized version of main study dataset, with one row per HOCI case included in the final analysis - HOCI_public_varlist: Variable descriptions for main study dataset - epi_data_combined: Weekly data on total SARS-CoV-2 +ve (cov_pos_epi) and -ve (cov_neg_epi) inpatients at each study site -community_incidence_summary: Weekly local community incidence data for each study site, per 100,000 people per week, obtained from UK government testing dashboard and weighted according to outer postcodes of inpatients at each site.

Notes on anonymisation: HOCI_public_dataset is an anonymised version of the main HOCI study database. In order to fully anonymise individuals, and because the focus of the study was on infection control actions rather than patient outcomes, all individual-level patient demographic and clinical characteristics have been removed. Site and ward names have been changed to anonymized codes, and all free text fields have been removed as some of these contained unblinded details of hospitals and wards. All date fields have been removed, with study week of SARS-CoV-2 +ve test result for each HOCI case provided.

Notes on acronyms: In ‘HOCI_public_varlist’, the following acronyms are used: AGP, aerosol-generating procedure CR, contact restrictions CT, contact tracing DIPC, Director of IPC HCAI, healthcare-associated infection HCW, healthcare worker IPC, infection prevention and control SR, sequence report SRO, sequence report output QM, quality management